vs
Perimeter Solutions, Inc.(PRM)与RIGEL PHARMACEUTICALS INC(RIGL)财务数据对比。点击上方公司名可切换其他公司
Perimeter Solutions, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.5倍($102.8M vs $69.8M),RIGEL PHARMACEUTICALS INC净利率更高(384.0% vs -136.5%,领先520.5%),RIGEL PHARMACEUTICALS INC同比增速更快(21.2% vs 19.2%),过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高(53.7% vs 31.9%)
Perimeter Solutions是一家以色列云与网络安全企业,专为各类机构打造基于零信任架构的安全远程网络方案,其技术可替代VPN、防火墙等传统安全硬件设备,助力企业简化网络安全部署,提升远程访问的安全性与效率。
Rigel制药是一家临床阶段生物技术企业,专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法,核心市场位于美国,旗下已获批产品可治疗成人免疫性血小板减少症,致力于满足未被覆盖的临床医疗需求。
PRM vs RIGL — 直观对比
营收规模更大
PRM
是对方的1.5倍
$69.8M
营收增速更快
RIGL
高出2.0%
19.2%
净利率更高
RIGL
高出520.5%
-136.5%
两年增速更快
RIGL
近两年复合增速
31.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $102.8M | $69.8M |
| 净利润 | $-140.2M | $268.1M |
| 毛利率 | 45.2% | 91.5% |
| 营业利润率 | -160.7% | 33.2% |
| 净利率 | -136.5% | 384.0% |
| 营收同比 | 19.2% | 21.2% |
| 净利润同比 | -197.3% | 1769.2% |
| 每股收益(稀释后) | $-0.89 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PRM
RIGL
| Q4 25 | $102.8M | $69.8M | ||
| Q3 25 | $315.4M | $69.5M | ||
| Q2 25 | $162.6M | $101.7M | ||
| Q1 25 | $72.0M | $53.3M | ||
| Q4 24 | $86.2M | $57.6M | ||
| Q3 24 | $288.4M | $55.3M | ||
| Q2 24 | $127.3M | $36.8M | ||
| Q1 24 | $59.0M | $29.5M |
净利润
PRM
RIGL
| Q4 25 | $-140.2M | $268.1M | ||
| Q3 25 | $-90.7M | $27.9M | ||
| Q2 25 | $-32.2M | $59.6M | ||
| Q1 25 | $56.7M | $11.4M | ||
| Q4 24 | $144.2M | $14.3M | ||
| Q3 24 | $-89.2M | $12.4M | ||
| Q2 24 | $21.6M | $-1.0M | ||
| Q1 24 | $-82.6M | $-8.2M |
毛利率
PRM
RIGL
| Q4 25 | 45.2% | 91.5% | ||
| Q3 25 | 63.1% | 93.2% | ||
| Q2 25 | 62.4% | 95.6% | ||
| Q1 25 | 39.1% | 91.7% | ||
| Q4 24 | 48.6% | 89.9% | ||
| Q3 24 | 62.8% | 85.5% | ||
| Q2 24 | 57.6% | 92.4% | ||
| Q1 24 | 35.1% | 93.1% |
营业利润率
PRM
RIGL
| Q4 25 | -160.7% | 33.2% | ||
| Q3 25 | -27.7% | 40.9% | ||
| Q2 25 | -16.1% | 60.1% | ||
| Q1 25 | — | 23.9% | ||
| Q4 24 | 71.1% | 28.9% | ||
| Q3 24 | -12.2% | 25.4% | ||
| Q2 24 | 35.4% | 1.2% | ||
| Q1 24 | -126.8% | -23.6% |
净利率
PRM
RIGL
| Q4 25 | -136.5% | 384.0% | ||
| Q3 25 | -28.7% | 40.2% | ||
| Q2 25 | -19.8% | 58.6% | ||
| Q1 25 | 78.7% | 21.5% | ||
| Q4 24 | 167.2% | 24.9% | ||
| Q3 24 | -30.9% | 22.5% | ||
| Q2 24 | 17.0% | -2.8% | ||
| Q1 24 | -139.8% | -27.9% |
每股收益(稀释后)
PRM
RIGL
| Q4 25 | $-0.89 | $14.11 | ||
| Q3 25 | $-0.62 | $1.46 | ||
| Q2 25 | $-0.22 | $3.28 | ||
| Q1 25 | $0.36 | $0.63 | ||
| Q4 24 | $1.00 | $0.82 | ||
| Q3 24 | $-0.61 | $0.70 | ||
| Q2 24 | $0.14 | $-0.06 | ||
| Q1 24 | $-0.57 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $325.9M | $155.0M |
| 总债务越低越好 | $669.1M | $52.5M |
| 股东权益账面价值 | $1.1B | $391.5M |
| 总资产 | $2.7B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.59× | 0.13× |
8季度趋势,按日历期对齐
现金及短期投资
PRM
RIGL
| Q4 25 | $325.9M | $155.0M | ||
| Q3 25 | $340.6M | $137.1M | ||
| Q2 25 | $140.7M | $108.4M | ||
| Q1 25 | $200.1M | $77.1M | ||
| Q4 24 | $198.5M | $77.3M | ||
| Q3 24 | $223.1M | $61.1M | ||
| Q2 24 | $43.2M | $49.1M | ||
| Q1 24 | $38.7M | $49.5M |
总债务
PRM
RIGL
| Q4 25 | $669.1M | $52.5M | ||
| Q3 25 | $668.8M | $60.0M | ||
| Q2 25 | $668.4M | $60.0M | ||
| Q1 25 | $668.1M | $60.0M | ||
| Q4 24 | $667.8M | $60.0M | ||
| Q3 24 | $667.4M | $60.0M | ||
| Q2 24 | $667.1M | $60.0M | ||
| Q1 24 | $666.8M | $60.0M |
股东权益
PRM
RIGL
| Q4 25 | $1.1B | $391.5M | ||
| Q3 25 | $1.1B | $117.6M | ||
| Q2 25 | $1.2B | $81.9M | ||
| Q1 25 | $1.2B | $18.6M | ||
| Q4 24 | $1.2B | $3.3M | ||
| Q3 24 | $1.0B | $-14.6M | ||
| Q2 24 | $1.1B | $-29.9M | ||
| Q1 24 | $1.1B | $-31.7M |
总资产
PRM
RIGL
| Q4 25 | $2.7B | $513.6M | ||
| Q3 25 | $2.6B | $242.5M | ||
| Q2 25 | $2.5B | $206.7M | ||
| Q1 25 | $2.4B | $176.0M | ||
| Q4 24 | $2.4B | $164.0M | ||
| Q3 24 | $2.5B | $139.4M | ||
| Q2 24 | $2.3B | $128.4M | ||
| Q1 24 | $2.3B | $126.5M |
负债/权益比
PRM
RIGL
| Q4 25 | 0.59× | 0.13× | ||
| Q3 25 | 0.60× | 0.51× | ||
| Q2 25 | 0.57× | 0.73× | ||
| Q1 25 | 0.55× | 3.23× | ||
| Q4 24 | 0.58× | 18.25× | ||
| Q3 24 | 0.67× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.63× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $18.6M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $11.6M | — |
| 自由现金流率自由现金流/营收 | 11.3% | — |
| 资本支出强度资本支出/营收 | 6.8% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $208.6M | — |
8季度趋势,按日历期对齐
经营现金流
PRM
RIGL
| Q4 25 | $18.6M | $22.0M | ||
| Q3 25 | $198.7M | $24.0M | ||
| Q2 25 | $-2.9M | $30.5M | ||
| Q1 25 | $23.7M | $-893.0K | ||
| Q4 24 | $-6.0M | $14.5M | ||
| Q3 24 | $183.0M | $21.7M | ||
| Q2 24 | $8.6M | $302.0K | ||
| Q1 24 | $2.8M | $-5.0M |
自由现金流
PRM
RIGL
| Q4 25 | $11.6M | — | ||
| Q3 25 | $193.6M | — | ||
| Q2 25 | $-15.6M | — | ||
| Q1 25 | $18.9M | — | ||
| Q4 24 | $-12.4M | — | ||
| Q3 24 | $179.1M | — | ||
| Q2 24 | $5.0M | — | ||
| Q1 24 | $1.2M | — |
自由现金流率
PRM
RIGL
| Q4 25 | 11.3% | — | ||
| Q3 25 | 61.4% | — | ||
| Q2 25 | -9.6% | — | ||
| Q1 25 | 26.3% | — | ||
| Q4 24 | -14.4% | — | ||
| Q3 24 | 62.1% | — | ||
| Q2 24 | 3.9% | — | ||
| Q1 24 | 2.1% | — |
资本支出强度
PRM
RIGL
| Q4 25 | 6.8% | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 7.8% | — | ||
| Q1 25 | 6.7% | — | ||
| Q4 24 | 7.5% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 2.9% | — | ||
| Q1 24 | 2.6% | — |
现金转化率
PRM
RIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | 0.42× | -0.08× | ||
| Q4 24 | -0.04× | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | 0.40× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRM
| Products | $87.7M | 85% |
| Service And Other | $14.8M | 14% |
RIGL
暂无分部数据